Lei Zhongwen, Yang Yijun, Xiang Yang
Department of Hepatobiliary Surgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, Hainan, China.
Haikou Key Laboratory of Clinical Research and Transformation of Digestive Diseases, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.
Front Bioeng Biotechnol. 2025 Jan 7;12:1501829. doi: 10.3389/fbioe.2024.1501829. eCollection 2024.
Biliary duct injury, biliary atresia (BA), biliary tract tumors, primary sclerosing cholangitis (PSC), and other diseases are commonly encountered in clinical practice within the digestive system. To gain a better understanding of the pathogenesis and development of these diseases and explore more effective treatment methods, organoid technology has recently garnered significant attention. Organoids are three-dimensional structures derived from stem/progenitor cells that can faithfully mimic the intricate structure and physiological function of tissues or organs . They provide a valuable platform for studying the pathogenesis of biliary tract diseases and offer novel possibilities for repairing and regenerating biliary tract injuries. The main seed cells used to construct biliary tract organoids include primary human biliary tract epithelial cells as well as pluripotent stem cells. The construction of these organoids involves various techniques such as traditional embedding technology, rotary culture technology, hanging drop culture technology, along with emerging approaches like organ chip technology, three-dimensional (3D) printing technology, and four-dimensional (4D) printing technology. This article comprehensively reviews the construction methods of biliary tract organoids while discussing their applications in disease modeling research on disease mechanisms drug screening tissue/organ repair; it also highlights current challenges and suggests future research directions regarding biliary tract organoids which will serve as references for treating common refractory digestive system diseases in clinical practice.
胆管损伤、胆道闭锁(BA)、胆道肿瘤、原发性硬化性胆管炎(PSC)等疾病在消化系统临床实践中较为常见。为了更好地了解这些疾病的发病机制和发展过程,并探索更有效的治疗方法,类器官技术最近受到了广泛关注。类器官是由干细胞/祖细胞衍生而来的三维结构,能够忠实地模拟组织或器官的复杂结构和生理功能。它们为研究胆道疾病的发病机制提供了一个有价值的平台,并为修复和再生胆道损伤提供了新的可能性。用于构建胆道类器官的主要种子细胞包括原代人胆道上皮细胞以及多能干细胞。这些类器官的构建涉及多种技术,如传统的包埋技术、旋转培养技术、悬滴培养技术,以及诸如器官芯片技术、三维(3D)打印技术和四维(4D)打印技术等新兴方法。本文全面综述了胆道类器官的构建方法,同时讨论了它们在疾病机制建模研究、药物筛选、组织/器官修复中的应用;还强调了当前面临的挑战,并提出了关于胆道类器官的未来研究方向,这将为临床实践中治疗常见难治性消化系统疾病提供参考。